19-24 May, 2019
PalmSpring, California, USA
ENYO Pharma will be present at The Mitochondrial Biogenesis and Dynamics in Health and Disease Conference meeting from the 19th to the 24th of May at Palm Spring and presented a poster on the topic: “Chemical targeting of NEET/CISDs proteins reveals the central role of mitochondrial morphodynamics regulation in viral infection”.
8th of may, 2019
Professor Rachel Nechuchstai of the Hebrew University in Jerusalem presented at the 8th Congress of the International Boiron Society in May a lecture entitled “The liability of the NEET proteins’ iron sulphur cluster: biomedical implications”. Professor Nechuchstai presented data generated in part through the close collaboration with ENYO Pharma on this topic.
10-14 April, 2019
ENYO Pharma team was present in Vienna from the 10th to the 14th of April at the EASL congress on liver diseases. On this occasion, several and fruitful discussions with various players took place. It was also the opportunity to present, in collaboration with the French research institut Inserm, a poster on the role of FXR and FXR agonists in the recruitment of HBx protein on HBV DNA.
26-28 March, 2019
ENYO Pharma has attended the China Healthcare Investment Conference from the 26th to the 28th of March, 2019. It was a great opportunity to initiate several financing and partneurship discussions.
7 – 10 January, 2019
San Francisco, USA
“ENYO Pharma team will be at San Francisco during the J.P. Morgan conference, which is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.” (jpmorgan.com)